Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Cardio Diagnostics Holdings (CDIO) Non Operating Income (2022 - 2025)

Cardio Diagnostics Holdings' Non Operating Income history spans 4 years, with the latest figure at -$2939.0 for Q3 2025.

  • For Q3 2025, Non Operating Income rose 18.34% year-over-year to -$2939.0; the TTM value through Sep 2025 reached -$14849.0, down 110.73%, while the annual FY2024 figure was -$17576.0, 98.45% up from the prior year.
  • Non Operating Income for Q3 2025 was -$2939.0 at Cardio Diagnostics Holdings, up from -$4500.0 in the prior quarter.
  • Across five years, Non Operating Income topped out at $670511.0 in Q1 2023 and bottomed at -$1.5 million in Q2 2023.
  • The 4-year median for Non Operating Income is -$4504.0 (2025), against an average of -$98186.8.
  • The largest YoY upside for Non Operating Income was 1266.11% in 2023 against a maximum downside of 2570.65% in 2023.
  • A 4-year view of Non Operating Income shows it stood at -$55034.0 in 2022, then surged by 378.14% to $153069.0 in 2023, then crashed by 101.9% to -$2906.0 in 2024, then dropped by 1.14% to -$2939.0 in 2025.
  • Per Business Quant, the three most recent readings for CDIO's Non Operating Income are -$2939.0 (Q3 2025), -$4500.0 (Q2 2025), and -$4504.0 (Q1 2025).